Stock ADUS ADDUS HOMECARE CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Financials Addus HomeCare Corporation

Equities

ADUS

US0067391062

Healthcare Facilities & Services

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
94.54 USD +3.10% Intraday chart for Addus HomeCare Corporation -2.73% +1.82%
Apr. 23 Addus HomeCare 'Disappointed' with Compensation Requirement in Medicaid Final Rule; Shares Tumble Pre-Bell MT
Apr. 23 Barclays Downgrades Addus HomeCare to Underweight From Equalweight, Cuts Price Target to $83 From $88 MT

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 1,498 1,834 1,475 1,587 1,486 1,529 - -
Enterprise Value (EV) 1 1,447 1,834 1,475 1,587 1,486 1,529 1,529 1,529
P/E ratio 53.7 x 56.3 x 33.3 x 35 x 24.2 x 21.7 x 19.4 x 16.9 x
Yield - - - - - - - -
Capitalization / Revenue 2.31 x 2.4 x 1.71 x 1.67 x 1.4 x 1.34 x 1.27 x 1.19 x
EV / Revenue 2.31 x 2.4 x 1.71 x 1.67 x 1.4 x 1.34 x 1.27 x 1.19 x
EV / EBITDA 25.5 x 23.8 x 15.1 x 15.6 x 12.3 x 11.8 x 10.9 x 10.2 x
EV / FCF 203 x 17.9 x 42.3 x 16.4 x 14.5 x 19.1 x 16.6 x 14.6 x
FCF Yield 0.49% 5.59% 2.36% 6.1% 6.92% 5.23% 6.02% 6.87%
Price to Book 3.19 x 3.57 x 2.6 x 2.53 x - - - -
Nbr of stocks (in thousands) 15,412 15,660 15,773 15,950 16,005 16,169 - -
Reference price 2 97.22 117.1 93.51 99.49 92.85 94.54 94.54 94.54
Announcement Date 3/17/20 2/25/21 2/24/22 2/27/23 2/26/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 648.8 764.8 864.5 951.1 1,059 1,144 1,206 1,285
EBITDA 1 58.7 76.91 97.66 101.5 121 129.4 139.7 149.2
EBIT 1 42.36 58.85 73.73 76.8 96.58 107.3 116.6 123.9
Operating Margin 6.53% 7.7% 8.53% 8.07% 9.12% 9.38% 9.67% 9.64%
Earnings before Tax (EBT) 1 33.17 41.94 60.4 60.17 81.33 94.74 106 119.3
Net income 1 25.24 33.13 45.13 46.02 62.52 71.53 79.98 89.72
Net margin 3.89% 4.33% 5.22% 4.84% 5.91% 6.25% 6.63% 6.98%
EPS 2 1.810 2.080 2.810 2.840 3.830 4.362 4.864 5.600
Free Cash Flow 1 7.398 102.6 34.84 96.81 102.8 80 92 105
FCF margin 1.14% 13.41% 4.03% 10.18% 9.71% 6.99% 7.63% 8.17%
FCF Conversion (EBITDA) 12.6% 133.38% 35.68% 95.4% 84.94% 61.81% 65.87% 70.4%
FCF Conversion (Net income) 29.31% 309.6% 77.21% 210.34% 164.43% 111.84% 115.04% 117.03%
Dividend per Share 2 - - - - - - - -
Announcement Date 3/17/20 2/25/21 2/24/22 2/27/23 2/26/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 216.7 224.6 226.6 236.9 240.5 247 251.6 260 270.7 276.4 280.4 284.6 288.5 290.2 294.7
EBITDA 1 24.87 26.71 22.41 25.1 25.72 28.25 26.04 28.3 30.86 34.26 30.31 31.53 32.67 34.9 33.01
EBIT 1 19.13 20.48 16.4 18.81 19.5 22.08 19.95 24.92 24.67 28.09 24.75 26.09 27.01 29.32 26.03
Operating Margin 8.83% 9.12% 7.24% 7.94% 8.11% 8.94% 7.93% 9.58% 9.11% 10.16% 8.83% 9.17% 9.36% 10.1% 8.83%
Earnings before Tax (EBT) 1 15.78 17.82 11.75 15.02 15.13 18.28 16.25 19.5 20.22 25.35 21.28 22.94 23.79 26.37 24.37
Net income 1 11.58 13.06 8.47 11.25 11.54 14.76 12.68 14.85 15.41 19.58 16.15 17.26 17.91 20.2 18.36
Net margin 5.34% 5.81% 3.74% 4.75% 4.8% 5.98% 5.04% 5.71% 5.69% 7.08% 5.76% 6.06% 6.21% 6.96% 6.23%
EPS 2 0.7200 0.8100 0.5300 0.7000 0.7100 0.9100 0.7800 0.9100 0.9500 1.200 0.9860 1.054 1.090 1.230 1.120
Dividend per Share - - - - - - - - - - - - - - -
Announcement Date 11/1/21 2/24/22 5/2/22 8/1/22 10/31/22 2/27/23 5/1/23 7/31/23 10/30/23 2/26/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt - - - - - - - -
Net Cash position 51.8 - - - - - - -
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 1 7.4 103 34.8 96.8 103 80 92 105
ROE (net income / shareholders' equity) 6.78% 9.88% 10.7% 9.99% 9.33% 9.92% 11% 11%
ROA (Net income/ Total Assets) 5.13% 6.43% 4.9% 6.4% - - - -
Assets 1 492.4 515.6 920.1 719.4 - - - -
Book Value Per Share 30.50 32.80 36.00 39.30 - - - -
Cash Flow per Share 2 - - - 6.500 6.880 6.180 6.440 -
Capex 1 4.62 6.83 4.65 8.3 9.45 11 13.2 -
Capex / Sales 0.71% 0.89% 0.54% 0.87% 0.89% 0.96% 1.09% -
Announcement Date 3/17/20 2/25/21 2/24/22 2/27/23 2/26/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Addus HomeCare Corporation

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
94.54 USD
Average target price
105.4 USD
Spread / Average Target
+11.52%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Home Healthcare Services

1st Jan change Capi.
ADDUS HOMECARE CORPORATION Stock Addus HomeCare Corporation
+1.82% 1.53B
AMEDISYS, INC. Stock Amedisys, Inc.
-3.44% 3B
BRIGHTSPRING HEALTH SERVICES, INC. Stock BrightSpring Health Services, Inc.
0.00% 1.81B
THE PENNANT GROUP, INC. Stock The Pennant Group, Inc.
+49.28% 624M
ENHABIT, INC. Stock Enhabit, Inc.
-3.09% 503M
DOCGO INC. Stock DocGo Inc.
-35.42% 368M
SAINT-CARE HOLDING CORPORATION Stock Saint-Care Holding Corporation
-13.04% 136M
KATO (HONG KONG) HOLDINGS LIMITED Stock Kato (Hong Kong) Holdings Limited
+1.92% 67.7M
Home Healthcare Services
  1. Stock Market
  2. Equities
  3. ADUS Stock
  4. Financials Addus HomeCare Corporation